Pfizer Inc. Financial Analysis
Current Price: $24.94 +0.77%
Market Cap: $142.14B
Sector: Healthcare
P/E Ratio: 18.21
Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplifie
Report Contents
- Income Statement Analysis (5-year history)
- Balance Sheet Overview
- Cash Flow Statement
- Key Financial Ratios
- Valuation Metrics (P/E, EV/EBITDA, P/S)
- Peer Comparison
- Revenue & Earnings Growth Trends
- Margin Analysis
- Analyst Price Targets
- DCF Valuation Model